Reputational risks are contributing to GPs shying away from healthcare provision in some European markets. Many are instead turning to other sub-sectors in the healthcare market, as Kenny Wastell reports
Visit our healthcare content hub here and read the first instalments of the series Across many of the more mature European healthcare markets, institutional fund managers have occasionally struggled...
GP acquired a majority stake in French ingredients producer Solina in 2015
Delisting after three years values the equity of Moleskine at €506m
VC acquired a majority stake in the group in 2012 alongside Calliode partners
VC hopes the appointment will strenghten its potential in the IT projects field